Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.7450 (-0.04%) ($13.7450 - $13.7450) on Tue. Oct. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.96% (three month average) | RSI | 57 | Latest Price | $13.7450(-0.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 5.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VUG(30%) XLK(30%) URA(29%) VT(29%) BLOK(28%) | Factors Impacting BCRX price | BCRX will decline at least -1.98% in a week (0% probabilities). SMH(-13%) VIXM(-12%) UUP(-11%) VXX(-2%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.98% (StdDev 3.96%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $13.91(-1.19%) | 10 Day Moving Average | $13.46(2.12%) | 20 Day Moving Average | $13.19(4.21%) | To recent high | -7.3% | To recent low | 27.6% | Market Cap | $2.425b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |